Stem Cell Therapies for the Lysosomal Storage Diseases - the Quintessential Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3946|3|2|88-98

ISSN： 1574-888X

Source： Current Stem Cell Research & Therapy, Vol.3, Iss.2, 2008-05, pp. : 88-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Therapies for Lysosomal Storage Diseases

By  

Current Molecular Medicine, Vol. 15, Iss. 8, 2015-09 ,pp. : 746-771

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Treatment for Neuronopathic Lysosomal Storage Diseases-Cell Therapy / Gene Therapy

By  

Current Molecular Medicine, Vol. 2, Iss. 1, 2002-02 ,pp. : 83-89

Bentham Science Publishers

Access to resources Recommend Favorite

Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases

By Krivit William  

Springer Seminars in Immunopathology, Vol. 26, Iss. 1-2, 2004-11 ,pp. : 119-132

Springer Publishing Company

Access to resources Recommend Favorite

Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases

By  

Current Stem Cell Research & Therapy, Vol. 9, Iss. 6, 2014-11 ,pp. : 513-521

Bentham Science Publishers

Access to resources Recommend Favorite

Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases - correction by surgical intervention

By Koc O.N.   Peters C.   Aubourg P.   Raghavan S.   Dyhouse S.   DeGasperi R.   Kolodny E.H.   BenYoseph Y.   Gerson S.L.   Lazarus H.M.   Caplan A.I.   Watkins P.A.   Krivit W.  

Experimental Hematology, Vol. 27, Iss. 11, 1999-11 ,pp. : 1675-1681

Elsevier

Access to resources Recommend Favorite